ONGOING CLINICAL TRIAL: A PROSPECTIVE MULTICENTRE, PHASE 2B RANDOMISED, CONTROLLED DOUBLE-BLIND TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF PERISPINAL ETANERCEPT ON QUALITY OF LIFE

被引：0
|
作者：
Thijs, V. [1 ]
Bernhardt, J. [1 ]
Cloud, G. [2 ]
Churilov, L. [3 ]
Sprigg, N. [4 ]
Parsons, B. [1 ]
Gilchrist, N. [5 ,6 ]
Walker, M. [6 ,7 ]
Bath, P. [7 ]
机构：
[1] Florey Inst Neurosci & Mental Hlth, Stroke Theme, Heidelberg, Vic, Australia
[2] Alfred Hlth, Stroke, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
[4] Univ Nottingham, Sch Med, Stroke Trials Unit, Nottingham, England
[5] CGM Res Trust, Cgm, Christchurch, New Zealand
[6] Univ Nottingham UK, Div Rehabil Ageing & Wellbeing, Nottingham, England
[7] Nottingham Univ Hosp NHS Trust, Stroke, Dept Med, Nottingham, England
来源：
INTERNATIONAL JOURNAL OF STROKE | 2021年 / 16卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WSC21-222
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial
    Beraha, Esther M.
    Salemink, Elske
    Goudriaan, Anna E.
    Bakker, Abraham
    de Jong, David
    Smits, Natasha
    Zwart, Jan Willem
    van Geest, Dick
    Bodewits, Pieter
    Schiphof, Tom
    Defourny, Harma
    van Tricht, Mirjam
    van den Brink, Wim
    Wiers, Reinout W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (12) : 1950 - 1959
  • [32] Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
    Cid, Maria C.
    Unizony, Sebastian H.
    Blockmans, Daniel
    Brouwer, Elisabeth
    Dagna, Lorenzo
    Dasgupta, Bhaskar
    Hellmich, Bernhard
    Molloy, Eamonn
    Salvarani, Carlo
    Trapnell, Bruce C.
    Warrington, Kenneth J.
    Wicks, Ian
    Samant, Manoj
    Zhou, Teresa
    Pupim, Lara
    Paolini, John F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 653 - 661
  • [33] Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial
    Ji, Linong
    Tong, Xiaolin
    Wang, Hongyuan
    Tian, Haoming
    Zhou, Huimin
    Zhang, Lili
    Li, Qifu
    Wang, Yizhong
    Li, Hongmei
    Liu, Min
    Yang, Hongjie
    Gao, Yanbin
    Li, Yan
    Li, Quanmin
    Guo, Xiaohui
    Yang, Gangyi
    Zhang, Zhongai
    Zhou, Zhiguang
    Ning, Guang
    Chen, Yingli
    Paul, Sanjoy
    PLOS ONE, 2013, 8 (02):
  • [34] Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial
    Taylor, Lyndsay
    Ahmada, Ahmada Ali
    Ali, Msanif Said
    Ali, Said Mohammed
    Hattendorf, Jan
    Mohammed, Ibrahim Said
    Keiser, Jennifer
    LANCET, 2024, 404 (10453): : 683 - 691
  • [35] EFFICACY AND SAFETY OF TELMISARTAN, CLOPIDOGRELIN, AND LEFLUNOMIDE IN PATIENTS WITH IgA NEPHROPATHY - A MULTICENTRE, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND -DUMMY CONTROLLED CLINICAL TRIAL
    Wu, Jie
    Duan, Shuwei
    Li, Wenge
    Wang, Yaping
    Liu, Wenhu
    Zhang, Jianrong
    Lun, Lide
    Li, Xuemei
    Zhou, Chunhua
    Zheng, Ying
    Liu, Shuwen
    Xie, Yuansheng
    Cai, Guangyan
    Chen, Xiangmei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 175 - 175
  • [36] Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
    Tyring, S
    Gottlieb, A
    Papp, K
    Gordon, K
    Leonardi, C
    Wang, A
    Lalla, D
    Woolley, M
    Jahreis, A
    Zitnik, R
    Cella, D
    Krishnan, R
    LANCET, 2006, 367 (9504): : 29 - 35
  • [37] Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial
    Coarelli, Giulia
    Heinzmann, Anna
    Ewenczyk, Claire
    Fischer, Clara
    Chupin, Marie
    Monin, Marie-Lorraine
    Hurmic, Hortense
    Calvas, Fabienne
    Calvas, Patrick
    Goizet, Cyril
    Thobois, Stephane
    Anheim, Mathieu
    Nguyen, Karine
    Devos, David
    Verny, Christophe
    Ricigliano, Vito A. G.
    Mangin, Jean-Francois
    Brice, Alexis
    du Montcel, Sophie Tezenas
    Durr, Alexandra
    LANCET NEUROLOGY, 2022, 21 (03): : 225 - 233
  • [38] Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Henzi, Bettina C.
    Schmidt, Simone
    Nagy, Sara
    Rubino-Nacht, Daniela
    Schaedelin, Sabine
    Putananickal, Niveditha
    Stimpson, Georgia
    Consortium, North Star
    Amthor, Helge
    Childs, Anne-Marie
    Deconinck, Nicolas
    de Groot, Imelda
    Horrocks, Iain
    Opstal, Saskia Houwen-van
    Laugel, Vincent
    Lobato, Mercedes Lopez
    Garrido, Marcos Madruga
    Osorio, Andres Nascimento
    Schara-Schmidt, Ulrike
    Spinty, Stefan
    von Moers, Arpad
    Lawrence, Fiona
    Hafner, Patricia
    Dorchies, Olivier M.
    Fischer, Dirk
    LANCET NEUROLOGY, 2023, 22 (10): : 890 - 899
  • [39] Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised double-blind, multicentre, placebo-controlled phase 3 trial
    Habib, Ali A.
    Zhao, Chongbo
    Aban, Inmaculada
    Franca Jr, Marcondes Cavalcante
    Jose, Jorge Gustavo
    Hoerste, Gerd Meyer zu
    Klimiec-Moskal, Elzbieta
    Pulley, Michael T.
    Tavolini, Dario
    Krumova, Petranka
    Lennon-Chrimes, Sian
    Smith, Jillian
    Thanei, Gian-Andrea
    Blondeau, Kathleen
    Vodopivec, Ivana
    Wolfe, Gil, I
    Murai, Hiroyuki
    LANCET NEUROLOGY, 2025, 24 (02): : 117 - 127
  • [40] Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
    Traboulsee, Anthony
    Greenberg, Benjamin M.
    Bennett, Jeffrey L.
    Szczechowski, Lech
    Fox, Edward
    Shkrobot, Svitlana
    Yamamura, Takashi
    Terada, Yusuke
    Kawata, Yuichi
    Wright, Padraig
    Gianella-Borradori, Athos
    Garren, Hideki
    Weinshenker, Brian G.
    LANCET NEUROLOGY, 2020, 19 (05): : 402 - 412
12345